본문 바로가기 주메뉴 바로가기
22대 대한민국 국회 국회정보길라잡이 국회의원검색
회원가입 로그인
HOME

정보검색

소장정보 검색

국회도서관 홈으로 정보검색 소장정보 검색
결과 내 검색 동의어 포함
결과 내 검색 동의어 포함

-

초록보기

Purpose Three years of adjuvant imatinib is the standard treatment for resected gastrointestinal stromal tumors (GISTs) with rupture, but the recurrence rate is prominently high. We aimed to investigate the efficacy and safety of 5-year adjuvant imatinib compared with 3-year treatment in patients with a ruptured GIST following surgical resection.

Materials and Methods A total of 51 patients were included in the analysis. The assessment of GIST rupture was based on Nishida’s classification. Twenty patients who were diagnosed before November 2013 were treated with 5 years of imatinib, and 31 patients who were diagnosed after November 2013 were treated with 3 years of imatinib. We retrospectively compared the clinical outcomes of the two groups.

Results Baseline characteristics and the incidence of the adverse events were generally comparable between the two groups. During a median follow-up duration of 43.8 months and 104.2 months in the 3- and 5-year group, 8 and 9 patients had a disease recurrence, respectively. The 5-year group showed better recurrence-free survival (RFS) than the 3-year group. In multivariate analysis, low mitotic index was a significant independent favorable prognostic factor for RFS, while 5-year imatinib treatment was marginally associated with a favorable RFS.

Conclusion Five years of adjuvant imatinib treatment in patients with ruptured GIST was associated with favorable survival outcomes with manageable toxicity profiles. Our findings warrant validation and confirmation in future studies.

권호기사

권호기사 목록 테이블로 기사명, 저자명, 페이지, 원문, 기사목차 순으로 되어있습니다.
기사명 저자명 페이지 원문 목차
(Editorial) Treating oligometastses, prelude or just hassles of systemic treatment Dae Ho Lee p. 951-952

Role of local treatment for oligometastasis : a comparability-based meta-analysis Chai Hong Rim, Won Kyung Cho, Jong Hoon Lee, Young Seok Kim, Yang-Gun Suh, Kyung Hwan Kim, Eui Kyu Chie, Yong Chan Ahn, The Oligometastasis Working Group, Korea Cancer Association p. 953-969

Reclassification of five BRCA1/2 variants with unknown significance using complex functional study Anikó Bozsik, János Papp, Vince Kornél Grolmusz, Attila Patócs, Edit Oláh, Henriett Butz p. 970-984

Assessment of anti-tumor efficacy of osimertinib in non–small cell lung cancer patients by liquid biopsy using bronchoalveolar lavage fluid, plasma, or pleural effusion Yeon Joo Kim, Won Jun Ji, Jae-Cheol Lee, Sung-Min Chun, Chang-Min Choi p. 985-995

(The) value of the illness-death model for predicting outcomes in patients with non–small cell lung cancer Kum Ju Chae, Hyemi Choi, Won Gi Jeong, Jinheum Kim p. 996-1004

(A) phase Ⅰ/Ⅱa randomized trial evaluating the safety and efficacy of SNK01 plus pembrolizumab in patients with stage Ⅳ non-small cell lung cancer Eo Jin Kim, Yong-Hee Cho, Dong Ha Kim, Dae-Hyun Ko, Eun-Ju Do, Sang-Yeob Kim, Yong Man Kim, Jae Seob Jung, Yoonmi Kang, Wonjun Ji, Myeong Geun Choi, Jae Cheol Lee, Jin Kyung Rho, Chang-Min Choi p. 1005-1016

(The) role of neutrophil-to-lymphocyte ratio in predicting pathological response for resectable non–small cell lung cancer treated with neoadjuvant chemotherapy combined with PD-1 checkpoint inhibitors Xiaoyan Sun, Yingnan Feng, Bin Zhang, Wuhao Huang, Xiaoliang Zhao, Hua Zhang, Dongsheng Yue, Changli Wang p. 1017-1029

Long-term exposure to PM10 increases lung cancer risks : a cohort analysis Hyun Woo Lee, Sung-Chan Kang, Sun-Young Kim, Young-Jae Cho, Seungsik Hwang p. 1030-1037

Clinical evidence of chemotherapy or endocrine therapy maintenance in patients with metastatic breast cancer : meta-analysis from randomized clinical trials and propensity score matching of multicentre cohort study Wei Ren, Yunfang Yu, Huangming Hong, Ying Wang, Quanlong Gao, Yongjian Chen, Peixian Chen, Jianli Zhao, Qiyun Ou, Dagui Lin ... [et al.] p. 1038-1052

Clinical significance of major angiogenesis-related effectors in patients with metastatic breast cancer treated with trastuzumab-based regimens Helen P. Kourea, Foteinos-Ioannis Dimitrakopoulos, Georgia-Angeliki Koliou, Anna Batistatou, Kyriaki Papadopoulou, Mattheos Bobos, Anthoula Asimaki-Vlachopoulou, Sofia Chrisafi, Kitty Pavlakis, Kyriakos Chatzopoulos ... [et al.] p. 1053-1064

Fear of cancer recurrence and its negative impact on health-related quality of life in long-term breast cancer survivors Thi Xuan Mai Tran, So-Youn Jung, Eun-Gyeong Lee, Heeyoun Cho, Na Yeon Kim, Sungkeun Shim, Ho Young Kim, Danbee Kang, Juhee Cho, Eunsook Lee, Yoon Jung Chang, Hyunsoon Cho p. 1065-1073

Lobular carcinoma in situ during preoperative biopsy and the rate of upgrade Jeea Lee, Ga Yoon Ku, Haemin Lee, Hyung Seok Park, Ja Seung Ku, Jee Ye Kim, Seho Park, Byeong-Woo Park p. 1074-1080

Effect of estrogen receptor expression level and hormonal therapy on prognosis of early breast cancer Kyung-Hwak Yoon, Yeshong Park, Eunyoung Kang, Eun-Kyu Kim, Jee Hyun Kim, Se Hyun Kim, Koung Jin Suh, Sun Mi Kim, Mijung Jang, Bo La Yun, So Yeon Park, Hee-Chul Shin p. 1081-1090

Real world evidence of neoadjuvant docetaxel/carboplatin/trastuzumab/pertuzumab (TCHP) in patients with HER2-positive early or locally advanced breast cancer : a single-institutional clinical experience Ji-Yeon Kim, Seok Jin Nam, Jeong Eon Lee, Jonghan Yu, Byung Joo Chae, Se Kyung Lee, Jai Min Ryu, Jin Seok Ahn, Young-Hyuck Im, Seok Won Kim, Yeon Hee Park p. 1091-1098

Implication and influence of multigene panel testing with genetic counseling in Korean patients with BRCA1/2 mutation-negative breast cancer Ji Soo Park, Saeam Shin, Yoon Jung Lee, Seung-Tae Lee, Eun Ji Nam, Jung Woo Han, Sun Hwa Lee, Tae Il Kim, Hyung Seok Park p. 1099-1110

(The) association of estrogen receptor activity, interferon signaling, and MHC class Ⅰ expression in breast cancer In Hye Song, Young-Ae Kim, Sun-Hee Heo, Won Seon Bang, Hye Seon Park, Yeon ho Choi, Heejae Lee, Jeong-Han Seo, Youngjin Cho, Sung Wook Jung, Hee Jeong Kim, Sei Hyun Ahn, Hee Jin Lee, Gyungyub Gong p. 1111-1120

(The) pattern of care for brain metastasis from breast cancer over the past 10 years in Korea : a multicenter retrospective study (KROG 16-12) Jae Sik Kim, Kyubo Kim, Wonguen Jung, Kyung Hwan Shin, Seock-Ah Im, Hee-Jun Kim, Yong Bae Kim, Jee Suk Chang, Jee Hyun Kim, Doo Ho Choi ... [et al.] p. 1121-1129

Real-world evidence of trastuzumab, pertuzumab, and docetaxel combination as a first-line treatment for Korean patients with HER2-positive metastatic breast cancer Yong-Pyo Lee, Min-Sang Lee, HongSik Kim, Ji-Yeon Kim, Jin Seok Ahn, Young-Hyuck Im, Yeon Hee Park p. 1130-1137

Prevalence of psychological symptoms in patients undergoing pancreatoduodenectomy and results of a distress management system : a clinic-based study Mee Joo Kang, Eun-Seung Yu, Young Hwa Kang, Hyeong Min Park, Sang-Jae Park, Sun-Whe Kim, Jong-Heun Kim, Sung-Sik Han p. 1138-1147

Role of esophagectomy after chemoradiation therapy in patients with locally advanced squamous cell carcinoma : a comparative analysis stratified by clinical response to chemoradiation therapy Jesang Yu, Jong Hoon Kim, Sung-Bae Kim, Sook Ryun Park, Young-Hee Kim, Hyeong Ryul Kim, Hyun Joo Lee, Ho June Song, Kye Jin Song, Jeong Yun Jang, Yoon Young Jo, Ye Jin Yoo p. 1148-1156

Aberrant DNA methylation maker for predicting metachronous recurrence after endoscopic resection of gastric neoplasms Cheol Min Shin, Nayoung Kim, Hyuk Yoon, Yoon Jin Choi, Ji Hyun Park, Young Soo Park, Dong Ho Lee p. 1157-1166

Adjuvant imatinib treatment for 5 years versus 3 years in patients with ruptured localized gastrointestinal stromal tumor : a retrospective analysis Sora Kang, Min-Hee Ryu, Yeong Hak Bang, Hyung-Don Kim, Hyung Eun Lee, Yoon-Koo Kang p. 1167-1174

Histopathologic and molecular biomarkers of PD-1/PD-L1 inhibitor treatment response among patients with microsatellite instability–high colon cancer Jaewon Hyung, Eun Jeong Cho, Jihun Kim, Jwa Hoon Kim, Jeong Eun Kim, Yong Sang Hong, Tae Won Kim, Chang Ohk Sung, Sun Young Kim p. 1175-1190

Optimal definition of biochemical recurrence in patients who receive salvage radiotherapy following radical prostatectomy for prostate cancer Sung Uk Lee, Jae-Sung Kim, Young Seok Kim, Jaeho Cho, Seo Hee Choi, Taek-Keun Nam, Song Mi Jeong, Youngkyong Kim, Youngmin Choi, Dong Eun Lee, Won Park, Kwan Ho Cho p. 1191-1199

Frequency of mismatch repair deficiency/high microsatellite instability and its role as a predictive biomarker of response to immune checkpoint inhibitors in gynecologic cancers Joseph J. Noh, Min Kyu Kim, Min Chul Choi, Jeong-Won Lee, Hyun Park, Sang Geun Jung, Won Duk Joo, Seung Hun Song, Chan Lee p. 1200-1208

Genomic correlates of unfavorable outcome in locally advanced cervical cancer treated with neoadjuvant chemoradiation Yuchun Wei, Chuqing Wei, Liang Chen, Ning Liu, Qiuxiang Ou, Jiani C. Yin, Jiaohui Pang, Zhenhao Fang, Xue Wu, Xiaonan Wang, Dianbin Mu, Yang Shao, Jinming Yu, Shuanghu Yuan p. 1209-1218

Identification of patients with recurrent epithelial ovarian cancer who will benefit from more than three lines of chemotherapy Aeran Seol, Ga Won Yim, Joo Yeon Chung, Se Ik Kim, Maria Lee, Hee Seung Kim, Hyun Hoon Chung, Jae-Weon Kim, Noh Hyun Park, Yong Sang Song p. 1219-1229

Outcome of intensive therapy for children with relapsed acute myeloid leukemia : a single institution Korean study Jae Wook Lee, Jae Won Yoo, Seongkoo Kim, Pil-Sang Jang, Nack-Gyun Chung, Bin Cho p. 1230-1239

Whole-genome and transcriptome sequencing identified NOTCH2 and HES1 as potential markers of response to imatinib in desmoid tumor (aggressive fibromatosis) : a phase Ⅱ trial study Joonha Kwon, Jun Hyeong Lee, Young Han Lee, Jeeyun Lee, Jin-Hee Ahn, Se Hyun Kim, Seung Hyun Kim, Tae Il Kim, Kum-Hee Yun, Young Suk Park, Jeong Eun Kim, Kyu Sang Lee, Jung Kyoon Choi, Hyo Song Kim p. 1240-1255

Predictive parameters of febrile neutropenia and clinical significance of G-CSF receptor signaling pathway in the development of neutropenia during R-CHOP chemotherapy with prophylactic pegfilgrastim in patients with diffuse large B-cell lymphoma Do Young Kim, Jehyun Nam, Joo-Seop Chung, Byeol Eun Jeon, Ji Hyun Lee, Jae-Cheol Jo, Sang-Woo Kim, Ho-Jin Shin p. 1256-1267

Pegfilgrastim prophylaxis is effective in the prevention of febrile neutropenia and reduces mortality in patients aged ≥ 75 years with diffuse large B-cell lymphoma treated with R-CHOP : a prospective cohort study Seong Hyun Jeong, Seok Jin Kim, Dok Hyun Yoon, Yong Park, Hye Jin Kang, Youngil Koh, Gyeong-Won Lee, Won-Sik Lee, Deok-Hwan Yang, Young Rok Do ... [et al.] p. 1268-1277

추천서가 (다양한 추천 자료를 만나보세요)

권호기사보기

권호기사 목록 테이블로 기사명, 저자명, 페이지, 원문, 기사목차 순으로 되어있습니다.
기사명 저자명 페이지 원문 기사목차